G, P., A, S., S, S., S, R., R, K., R, S., . . . M, G. (2026). SNHG10 promotes tumorigenesis through the EGFR/AKT/ERK/mTOR and miR-150-5p/VEGF-A axis, along with gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell death discovery, 12(1), . https://doi.org/10.1038/s41420-026-03040-y
Chicago Style (17th ed.) CitationG, Pandya, et al. "SNHG10 Promotes Tumorigenesis Through the EGFR/AKT/ERK/mTOR and MiR-150-5p/VEGF-A Axis, Along with Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma." Cell Death Discovery 12, no. 1 (2026). https://doi.org/10.1038/s41420-026-03040-y.
MLA (9th ed.) CitationG, Pandya, et al. "SNHG10 Promotes Tumorigenesis Through the EGFR/AKT/ERK/mTOR and MiR-150-5p/VEGF-A Axis, Along with Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma." Cell Death Discovery, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41420-026-03040-y.